Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?

Background. Serum TSH levels in the upper-normal range were reported to be associated with increased risk of thyroid malignancy. However, measurement of TSH levels is currently not recommended for assessing the risk of malignancy in patients with newly diagnosed thyroid nodules. Objective. To evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlo Cappelli, Ilenia Pirola, Elena Gandossi, Mario Rotondi, Davide Lombardi, Claudio Casella, Fiorella Marini, Maura Saullo, Barbara Agosti, Elena Di Lodovico, Luca Chiovato, Alberto Ferlin, Maurizio Castellano
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2020/7543930
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546919844413440
author Carlo Cappelli
Ilenia Pirola
Elena Gandossi
Mario Rotondi
Davide Lombardi
Claudio Casella
Fiorella Marini
Maura Saullo
Barbara Agosti
Elena Di Lodovico
Luca Chiovato
Alberto Ferlin
Maurizio Castellano
author_facet Carlo Cappelli
Ilenia Pirola
Elena Gandossi
Mario Rotondi
Davide Lombardi
Claudio Casella
Fiorella Marini
Maura Saullo
Barbara Agosti
Elena Di Lodovico
Luca Chiovato
Alberto Ferlin
Maurizio Castellano
author_sort Carlo Cappelli
collection DOAJ
description Background. Serum TSH levels in the upper-normal range were reported to be associated with increased risk of thyroid malignancy. However, measurement of TSH levels is currently not recommended for assessing the risk of malignancy in patients with newly diagnosed thyroid nodules. Objective. To evaluate a possible relationship between the serum levels of TSH and the histological outcome of patients undergoing thyroidectomy for thyroid nodules with indeterminate cytology. Materials and Methods. We collected the clinical data of all patients who had performed ultrasound-guided FNA of thyroid nodules with cytological diagnosis of indeterminate lesions (TIR3A and TIR3B) and serum TSH levels within the normal range. All patients had been submitted to thyroid surgery (hemi or thyroidectomy, as appropriate), and histological diagnosis had been performed. Results. A histological diagnosis of thyroid malignancy was rendered in 74/378 (19.6%) nodules. Patients with histologically proven thyroid malignancy were characterized by higher serum levels of TSH as compared to patients with histologically proven benign nodules (3.03 ± 1.16 vs. 2.37 ± 1.19 mIU/L, p<0.001). To further analyze the role of serum TSH in predicting thyroid cancer, patients were stratified in 4 groups according to quartiles of TSH concentrations. The prevalence of malignancy was 12.2% for the first quartile and 50.0% for the last quartile. ROC curve analysis identified that a serum TSH level of ≥2.7 mIU/L predicted thyroid malignancy with a sensitivity of 61% and a specificity of 65%. Conclusions. TSH levels in the upper-normal range are associated with an increased risk of thyroid malignancy in patients affected by thyroid nodules with indeterminate cytology at FNA. The measurement of serum TSH levels represents an easily performed additional tool for decision-making in patients with indeterminate cytological findings.
format Article
id doaj-art-0498df65ba70476d9067903206fb1c8a
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-0498df65ba70476d9067903206fb1c8a2025-02-03T06:46:36ZengWileyInternational Journal of Endocrinology1687-83371687-83452020-01-01202010.1155/2020/75439307543930Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?Carlo Cappelli0Ilenia Pirola1Elena Gandossi2Mario Rotondi3Davide Lombardi4Claudio Casella5Fiorella Marini6Maura Saullo7Barbara Agosti8Elena Di Lodovico9Luca Chiovato10Alberto Ferlin11Maurizio Castellano12Department of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyUnit of Internal Medicine and Endocrinology, ICS Maugeri IRCCS, Laboratory for Endocrine Disruptors, University of Pavia, Pavia, ItalyDepartment of Otorhinolaryngology—Head and Neck Surgery, University of Brescia, Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyUnit of Internal Medicine and Endocrinology, ICS Maugeri IRCCS, Laboratory for Endocrine Disruptors, University of Pavia, Pavia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Clinical and Experimental Sciences, SSD Medicina ad Indirizzo Endocrino-metabolico, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyBackground. Serum TSH levels in the upper-normal range were reported to be associated with increased risk of thyroid malignancy. However, measurement of TSH levels is currently not recommended for assessing the risk of malignancy in patients with newly diagnosed thyroid nodules. Objective. To evaluate a possible relationship between the serum levels of TSH and the histological outcome of patients undergoing thyroidectomy for thyroid nodules with indeterminate cytology. Materials and Methods. We collected the clinical data of all patients who had performed ultrasound-guided FNA of thyroid nodules with cytological diagnosis of indeterminate lesions (TIR3A and TIR3B) and serum TSH levels within the normal range. All patients had been submitted to thyroid surgery (hemi or thyroidectomy, as appropriate), and histological diagnosis had been performed. Results. A histological diagnosis of thyroid malignancy was rendered in 74/378 (19.6%) nodules. Patients with histologically proven thyroid malignancy were characterized by higher serum levels of TSH as compared to patients with histologically proven benign nodules (3.03 ± 1.16 vs. 2.37 ± 1.19 mIU/L, p<0.001). To further analyze the role of serum TSH in predicting thyroid cancer, patients were stratified in 4 groups according to quartiles of TSH concentrations. The prevalence of malignancy was 12.2% for the first quartile and 50.0% for the last quartile. ROC curve analysis identified that a serum TSH level of ≥2.7 mIU/L predicted thyroid malignancy with a sensitivity of 61% and a specificity of 65%. Conclusions. TSH levels in the upper-normal range are associated with an increased risk of thyroid malignancy in patients affected by thyroid nodules with indeterminate cytology at FNA. The measurement of serum TSH levels represents an easily performed additional tool for decision-making in patients with indeterminate cytological findings.http://dx.doi.org/10.1155/2020/7543930
spellingShingle Carlo Cappelli
Ilenia Pirola
Elena Gandossi
Mario Rotondi
Davide Lombardi
Claudio Casella
Fiorella Marini
Maura Saullo
Barbara Agosti
Elena Di Lodovico
Luca Chiovato
Alberto Ferlin
Maurizio Castellano
Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
International Journal of Endocrinology
title Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
title_full Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
title_fullStr Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
title_full_unstemmed Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
title_short Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
title_sort could serum tsh levels predict malignancy in euthyroid patients affected by thyroid nodules with indeterminate cytology
url http://dx.doi.org/10.1155/2020/7543930
work_keys_str_mv AT carlocappelli couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT ileniapirola couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT elenagandossi couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT mariorotondi couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT davidelombardi couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT claudiocasella couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT fiorellamarini couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT maurasaullo couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT barbaraagosti couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT elenadilodovico couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT lucachiovato couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT albertoferlin couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology
AT mauriziocastellano couldserumtshlevelspredictmalignancyineuthyroidpatientsaffectedbythyroidnoduleswithindeterminatecytology